Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 3/2010

01-10-2010 | Poster presentation

Does a second image-guided biopsy contribute to the management of B3 lesions?

Authors: JK Juttla, W Teh

Published in: Breast Cancer Research | Special Issue 3/2010

Login to get access

Excerpt

B3 (benign with uncertain malignant potential) lesions such as atypias and papillary lesions have final surgical outcome of malignancy in about 20% of vacuum-assisted and 45% of image-guided core biopsies. We examine the benefits of undertaking a second image-guided biopsy in these cases. …
Metadata
Title
Does a second image-guided biopsy contribute to the management of B3 lesions?
Authors
JK Juttla
W Teh
Publication date
01-10-2010
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 3/2010
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr2683

Other articles of this Special Issue 3/2010

Breast Cancer Research 3/2010 Go to the issue

Poster presentation

Breast cancer screening in the over 70s

Poster presentation

Educational abstract

Poster presentation

Effect of the introduction of preoperative MRI scans for lobular cancer in an individual breast unit

Poster presentation

Two-view 2D digital mammography versus one-view digital breast tomosynthesis

Poster presentation

Correlation of preoperative ultrasound and mammographic measurement of malignant breast masses with operative histology

Oral presentation

Size matters: second breast cancer size following treatment for primary cancer as a predictor of survival
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits